UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000008535
Receipt No. R000010031
Scientific Title Phase III Study of High-dose Methotrexate and Whole Brain Radiotherapy With or Without Concomitant and Adjuvant Temozolomide in Patients with Primary CNS Lymphoma (JCOG1114C, PCNSL-TMZ-P3)
Date of disclosure of the study information 2014/07/30
Last modified on 2018/04/19 15:44:30

No. Disposal Last modified on Item of update
1 Insert 2012/07/25 23:07:07
2 Update 2012/07/27 18:37:25 UMIN ID1
3 Update 2012/09/27 17:08:37 Date of disclosure of the study information
4 Update 2012/11/14 10:41:13 Anticipated trial start date
Last follow-up date
5 Update 2012/11/14 10:41:41 Date of disclosure of the study information
6 Update 2013/03/19 20:11:25 Anticipated trial start date
Last follow-up date
7 Update 2013/03/19 20:11:48 Date of disclosure of the study information
8 Update 2013/06/13 13:48:03 Date of disclosure of the study information
9 Update 2013/09/13 20:36:38 Email
Date of disclosure of the study information
10 Update 2014/02/14 11:27:46 Date of disclosure of the study information
11 Update 2014/04/02 11:11:25 Date of disclosure of the study information
12 Update 2014/05/29 14:35:30 Date of disclosure of the study information
13 Update 2014/07/30 13:58:01 Public title
Public title
Acronym
Acronym
14 Update 2014/07/30 14:00:48 Condition
Narrative objectives1
Narrative objectives1
Key secondary outcomes
Key secondary outcomes
15 Update 2014/07/30 14:10:39 Randomization unit
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
16 Update 2014/07/30 14:16:49 Organization
Address
Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
Homepage URL
Email
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Institute
Institute
Organization
Organization
Category of Funding Organization
Organization1
Address1
Tel1
Email1
Institutions
17 Update 2014/07/30 14:17:55 Anticipated trial start date
Last follow-up date
18 Update 2014/09/29 10:12:43 Recruitment status
Anticipated trial start date
Last follow-up date
19 Update 2014/10/03 14:19:45 Key inclusion criteria
20 Update 2015/11/27 10:41:50 Other related information
Other related information
21 Update 2018/01/30 15:16:26 Name of primary sponsor
Organization
Organization
Organization
Institutions
22 Update 2018/01/30 15:18:18 Last follow-up date
23 Update 2018/02/27 18:18:08 Institutions
24 Update 2018/04/19 15:31:30 Public title
Public title
Acronym
Acronym
25 Update 2018/04/19 15:38:34 Key inclusion criteria
Key inclusion criteria
26 Update 2018/04/19 15:44:30 Organization
Organization
Division name


Contact us.